Dr. Maran Thamilarasan, MD

Dr. Thamilarasan practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Thamilarasan's NPI, 1851492755, was assigned on September 26, 2006. Dr. Thamilarasan graduated from University of Michigan Medical School in 1992. Dr. Thamilarasan holds Ohio license 35077655.

Dr. Thamilarasan's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Thamilarasan's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Thamilarasan is also affiliated with Medina Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Thamilarasan to 3 more hospitals, 2 clinical labs and 1 medical group, each named with a free account. Dr. Thamilarasan's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thamilarasan practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Thamilarasan's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Thamilarasan is licensed in Ohio.

CMS data shows 2,290 Medicare services from Dr. Thamilarasan across 16 procedure codes in 2024, for 1,286 Medicare patients. Medicare paid $75,058 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,286 Medicare patients who saw Dr. Thamilarasan in 2024. The largest group is 65 to 74, with 620 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thamilarasan's median patient age at 64, with 43% women.

In 2024, Dr. Thamilarasan wrote 2,622 Medicare Part D claims for 294 patients. 84% of them were for generic drugs. CMS names the drug for 2,402 of them, across 29 drugs with 11 or more claims each, at $963,244 in total drug cost. In 2023, CMS named 2,014 claims across 33 drugs.

Dr. Thamilarasan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Thamilarasan as offering telehealth.

Dmand AI links 40 papers to Dr. Thamilarasan, published from 2012 to 2025. 2024 was the busiest year, with 9. The most frequent topics are Cardiomyopathy, Hypertrophic, Ventricular Function, Left and Echocardiography. Dr. Thamilarasan has published most often in J Am Heart Assoc. Dr. Thamilarasan's most frequent co-authors are Milind Y. Desai, MD, Nicholas G. Smedira, MD and Harry M. Lever, MD.

Dr. Thamilarasan graduated from University of Michigan Medical School in 1992.